BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yu TW, Lane HY, Lin CH. Novel Therapeutic Approaches for Alzheimer's Disease: An Updated Review. Int J Mol Sci 2021;22:8208. [PMID: 34360973 DOI: 10.3390/ijms22158208] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 6.5] [Reference Citation Analysis]
Number Citing Articles
1 Cao B, Zeng M, Hao F, Zhao C, Zhang B, Wu Y, Zhang Y, Li M, Feng W, Zheng X. Two polyphenols isolated from Corallodiscus flabellata B. L. Burtt ameliorate amyloid β-protein induced Alzheimer's disease neuronal injury by improving mitochondrial homeostasis. Behav Brain Res 2023;440:114264. [PMID: 36535434 DOI: 10.1016/j.bbr.2022.114264] [Reference Citation Analysis]
2 Budak M, Bayraktaroglu Z, Hanoglu L. The effects of repetitive transcranial magnetic stimulation and aerobic exercise on cognition, balance and functional brain networks in patients with Alzheimer's disease. Cogn Neurodyn 2023;17:39-61. [PMID: 36704634 DOI: 10.1007/s11571-022-09818-x] [Reference Citation Analysis]
3 Baltissen D, Bold CS, Rehra L, Banićević M, Fricke J, Just J, Ludewig S, Buchholz CJ, Korte M, Müller UC. APPsα rescues CDK5 and GSK3β dysregulation and restores normal spine density in Tau transgenic mice. Front Cell Neurosci 2023;17. [DOI: 10.3389/fncel.2023.1106176] [Reference Citation Analysis]
4 Pérez-carrión MD, Posadas I. Dendrimers in Neurodegenerative Diseases. Processes 2023;11:319. [DOI: 10.3390/pr11020319] [Reference Citation Analysis]
5 Jung H, Lee Y, Lee SH, Sohn JH. Auditory or Audiovisual Stimulation Ameliorates Cognitive Impairment and Neuropathology in ApoE4 Knock-In Mice. Int J Mol Sci 2023;24. [PMID: 36674449 DOI: 10.3390/ijms24020938] [Reference Citation Analysis]
6 Neha, Parvez S. Emerging therapeutics agents and recent advances in drug repurposing for Alzheimer's disease. Ageing Res Rev 2022;85:101815. [PMID: 36529440 DOI: 10.1016/j.arr.2022.101815] [Reference Citation Analysis]
7 Yenkoyan K, Margaryan T, Matinyan S, Chavushyan V, Danielyan M, Davtyan T, Aghajanov M. Effects of β-amyloid (1-42) Administration on the Main Neurogenic Niches of the Adult Brain: Amyloid-Induced Neurodegeneration Influences Neurogenesis. Int J Mol Sci 2022;23. [PMID: 36499771 DOI: 10.3390/ijms232315444] [Reference Citation Analysis]
8 Sun W, Song J, Dong X, Kang X, He B, Zhao W, Li Z, Feng Z, Chen X. Bibliometric and visual analysis of transcranial direct current stimulation in the web of science database from 2000 to 2022 via CiteSpace. Front Hum Neurosci 2022;16:1049572. [PMID: 36530203 DOI: 10.3389/fnhum.2022.1049572] [Reference Citation Analysis]
9 Li Y, Lai W, Zheng C, Babu JR, Xue C, Ai Q, Huggins KW. Neuroprotective Effect of Stearidonic Acid on Amyloid β-Induced Neurotoxicity in Rat Hippocampal Cells. Antioxidants (Basel) 2022;11. [PMID: 36552565 DOI: 10.3390/antiox11122357] [Reference Citation Analysis]
10 Siafaka PI, Okur ME, Erim PD, Çağlar EŞ, Özgenç E, Gündoğdu E, Köprülü REP, Karantas ID, Üstündağ Okur N. Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today? Pharmaceutics 2022;14:2425. [DOI: 10.3390/pharmaceutics14112425] [Reference Citation Analysis]
11 Yadav P, Lee YH, Panday H, Kant S, Bajwa N, Parashar R, Jha SK, Jha NK, Nand P, Lee SS, Jha AK. Implications of Microorganisms in Alzheimer's Disease. Curr Issues Mol Biol 2022;44:4584-615. [PMID: 36286029 DOI: 10.3390/cimb44100314] [Reference Citation Analysis]
12 Song Y, Zhu X, Zhang X, Xiong H. Targeted Mitochondrial Epigenetics: A New Direction in Alzheimer’s Disease Treatment. IJMS 2022;23:9703. [DOI: 10.3390/ijms23179703] [Reference Citation Analysis]
13 Calvino M, Sánchez-cuadrado I, Gavilán J, Lassaletta L. The effect of risk factors on cognition in adult cochlear implant candidates with severe to profound hearing loss. Front Psychol 2022;13:837366. [DOI: 10.3389/fpsyg.2022.837366] [Reference Citation Analysis]
14 Ahmad F, Sachdeva P. Critical appraisal on mitochondrial dysfunction in Alzheimer's disease. Aging Med (Milton) 2022;5:272-80. [PMID: 36606272 DOI: 10.1002/agm2.12217] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Schreiner TG, Menéndez-González M, Popescu BO. The "Cerebrospinal Fluid Sink Therapeutic Strategy" in Alzheimer's Disease-From Theory to Design of Applied Systems. Biomedicines 2022;10:1509. [PMID: 35884814 DOI: 10.3390/biomedicines10071509] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Colca JR, Finck BN. Metabolic Mechanisms Connecting Alzheimer’s and Parkinson’s Diseases: Potential Avenues for Novel Therapeutic Approaches. Front Mol Biosci 2022;9:929328. [DOI: 10.3389/fmolb.2022.929328] [Reference Citation Analysis]
17 Krafft GA, Jerecic J, Siemers E, Cline EN. ACU193: An Immunotherapeutic Poised to Test the Amyloid β Oligomer Hypothesis of Alzheimer’s Disease. Front Neurosci 2022;16:848215. [DOI: 10.3389/fnins.2022.848215] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Stanczykiewicz B, Gburek J, Rutkowska M, Lemieszewska M, Gołąb K, Juszczyńska K, Piotrowska A, Trziszka T, Dzięgiel P, Podhorska-okołów M, Zabłocka A, Rymaszewska J. Ovocystatin Induced Changes in Expression of Alzheimer’s Disease Relevant Proteins in APP/PS1 Transgenic Mice. JCM 2022;11:2372. [DOI: 10.3390/jcm11092372] [Reference Citation Analysis]
19 Wang Q, Duan L, Li X, Wang Y, Guo W, Guan F, Ma S. Glucose Metabolism, Neural Cell Senescence and Alzheimer’s Disease. IJMS 2022;23:4351. [DOI: 10.3390/ijms23084351] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
20 Pottoo FH, Ibrahim AM, Alammar A, Alsinan R, Aleid M, Alshehhi A, Alshehri M, Mishra S, Alhajri N. Thymoquinone: Review of Its Potential in the Treatment of Neurological Diseases. Pharmaceuticals 2022;15:408. [DOI: 10.3390/ph15040408] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
21 Araki W, Kametani F. Protection against Amyloid-β Oligomer Neurotoxicity by Small Molecules with Antioxidative Properties: Potential for the Prevention of Alzheimer’s Disease Dementia. Antioxidants 2022;11:132. [DOI: 10.3390/antiox11010132] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
22 Santiago-Mujika E, Luthi-Carter R, Giorgini F, Kalaria RN, Mukaetova-Ladinska EB. Tubulin and Tubulin Posttranslational Modifications in Alzheimer's Disease and Vascular Dementia. Front Aging Neurosci 2021;13:730107. [PMID: 34776926 DOI: 10.3389/fnagi.2021.730107] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
23 Park JS, Kim T, Kim D, Jeong YI. The Effect of Oxidative Stress and Memantine-Incorporated Reactive Oxygen Species-Sensitive Nanoparticles on the Expression of N-Methyl-d-aspartate Receptor Subunit 1 in Brain Cancer Cells for Alzheimer's Disease Application. Int J Mol Sci 2021;22:12309. [PMID: 34830191 DOI: 10.3390/ijms222212309] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]